Horizon Discovery, a PerkinElmer company, drives the application of gene editing and gene modulation to enable world-leading academic institutes, pharmaceutical and biotechnology companies, as well as clinical diagnostic laboratories, to identify the genetic drivers behind human disease, develop and validate diagnostic workflows, and deliver new therapies for precision medicine.With more than a decade of experience in the engineering of cell lines, Horizon offers innovative tools and services based upon the ability to modulate, or permanently alter, the function of almost any gene in human and other mammalian cell lines.Horizon is headquartered in Cambridge, UK with offices in USA and Japan.

Precision Genome Engineering (CRISPR rAAV & ZFN) Functional Genomic Screening X-MAN® (gene-X Mutant And Normal) Cell Lines Specialist Assay Services HDx™ Reference Standards Drug Combination Screening SAGE® In Vivo Models and Services Bioproduction Reference Standards Gene Editing In Vivo Models PDX Drug Development Services rAAV Cell Lines Bioproduction Cell Lines Cell Line Engineering High Throughput Screening Combination High Throughput Screening Cell Based Assays CRISPR Reagents SiRNA RNA Animal Models Gene Editing Gene Modulation siRNA T cell screening Custom RNA synthesis Edited CHO cells Functional genomic screening CRISPR reagents Gene modulation Cell line engineering Gene editing Reference standards Molecular diagnostics Cell lines Cell based assays CRISPR CRISPRa CRISPRi Bioproduction cell lines shRNA noncoding RNA miRNA